. Even more recently, the profound effects that hypoxia can have on the actions of cytokines, including interleukin 2 (IL-2), tumour necrosis factor alpha (TNF-a) and interferon (IFN), have been described (Aune and Pogue, 1989; Ishizaka et al., 1992; Sampson and Chaplin, 1994) .
It was nearly 40 years ago that Thomlinson and Gray (1955) first focused radiation biologists' and therapists' attention on the profound effects that hypoxia has on cellular response to radiation. Subsequent studies in the 1970s and 1980s demonstrated that the level of oxygen in which cells are grown can alter their responsiveness to a number of chemotherapeutic agents (Teicher et al., 1981) . Even more recently, the profound effects that hypoxia can have on the actions of cytokines, including interleukin 2 (IL-2), tumour necrosis factor alpha (TNF-a) and interferon (IFN), have been described (Aune and Pogue, 1989; Ishizaka et al., 1992; Sampson and Chaplin, 1994) .
It has been known for many years that radiobiologicaly hypoxic cells exist in experimental rodent and xenografted human tumours. The recent availability of the Eppendorf Po2 histograph has enabled the demonstration of hypoxic regions in primary human tumours (Vaupel et al., 1991; Hockel et al., 1993) . Despite our knowledge of the existence of hypoxic cells in tumours and the undoubted importance of hypoxia to therapeutic response, relatively little attention has been focused on how hyponia arises within a solid tumour mass. Knowledge as to how hypoxic cells occur has important impi;cations for the approaches that can be used to improve the oxygenation status of cells and ultimately therapeutic response. Moreover, in order to mimic more closely in vitro the nutritional and physiological status of hypoxic cells in vivo, knowledge of how they occur and how long they remain hypoxic represents important information.
On a theoretical basis, hypoxic cells can result from two distinct processes: firstly from diffusion limitations in a system with a constant blood flow and oxygen delivery capacity; cell division and oxygen ultilisation by those cells closest to the blood vessel result in a gradual decline in the oxygenation and nutritional status of cells further away.
Alternatively, hypoxic cells could result from perfusiondriven changes in oxygen supply. Such cells could be subjected to rapid and potentially reversible changes in their oxygenation and nutritional status. In their original studies, Thomlinson and Gray (1955) proposed a model of 'diffusionlimited' hypoxic cells existing distant from blood vessels. This is now known not to be the sole cause of clonogenic hypoxic cells in tumours. Indirect evidence, including the fact that following radiation treatment regrowth could occur from well-vascularised tumour microregions (Yamaura and Matsuzawa, 1979 ) and that two populations of hypoxic cells with different radiosensitivities could be detected in the RIF tumour (Brown, 1979) , led to the postulate that some hypoxic cells arose from dynamic microcirculation changes within tumours. More direct evidence from 'sandwich' tumour preparations has shown that microvascular flow is chaotic and can lead to vessels being temporarily nonperfused (Reinhold et al., 1977) . The fact that clonogenic, radiobiologically hypoxic cells can result from dynamic changes in microregional perfusion was confirmed with the development of techniques which utilised fluorescent perfusion markers in conjunction with flow cytometry (Chaplin et al., 1987) . The subsequent development of histological techniques which utilise two fluorescent perfusion markers whose intravenous administration is separated in time has clearly shown that temporal changes in microregional perfusion are observed in many experimental solid tumour systems (Chaplin and Trotter, 1991 January 1995 10 years. Subcutaneous tumours were initiated by injecting 0.05 ml of a crude cell suspension under the skin of the rear dorsum of 12-to 16-week-old CBA, Gy f TO mice. Animals were selected when their tumours reached 5.5 -6.5 mm geometric mean diameter (150-300mg Figure 2 . where several changes in flow are apparent over the 60 mmn period of analysis. Also of particular note is that 20% of the traces demonstrate a change in erythrocyte flux by at least a factor of 5. It can also be seen from the table that the frequency and magnitude of fluctuation are similar in both tumour types.
One of the potential problems with laser Doppler studies is that apparent changes in flow may be due to probe movement; we therefore investigated whether the fluctuations seen in the CaNT were similar in anaesthetised and unanaesthetised animals. The data presented in Table I show that similar results were obtained in both experimental groups, suggesting that movement artifacts are excluded by our analysis procedure. Of interest is that similar temporal changes were seen despite the fact that anaesthetic reduced the initial erythrocyte flux by 60% (data not shown). In order to gain further insight into the kinetics of the changes observed in erythrocyte flux in tumour microregions. the traces were analysed further. The results shown in Table II excluded from the data analysis. The fact that similar changes are observed in anaesthetised as well as unanaesthetised animals provides a strong indication that movement artifacts are excluded using the current analysis procedure.
In summary. the current study demonstrates the potential of real-time spatial flow mapping using laser Doppler microprobes for detecting temporal changes in microregional erythrocyte flux in three-dimensional solid tumour systems. The results obtained demonstrate that in the two experimental tumours assessed such changes are frequently observed. Both of the tumours used have radiobiologically hypoxic fractions > 30%; thus, based on our current work, temporal fluctuations in flow could contribute significantly to this value. Further studies are now needed on other tumours, including those that are slower growing and more differentiated, to determine the generality of the current findings. If temporal changes in red blood cell flux, and thus tumour cell oxygenation, are a common feature of solid tumours, then procedures which improve the oxygen-carrying capacity of the blood will not be effective in reoxygenating all the hypoxic cell population. Knowledge that cells may be subjected to changing oxygenation levels of variable duration could also be important in the design of in vitro experiments which attempt to mimic in vivo conditions. This may be of particular relevance in studies which examine the influence of oxygenation status on gene expression.
